4.6 Article

Glucose Enhances Pro-Tumorigenic Functions of Mammary Adipose-Derived Mesenchymal Stromal/Stem Cells on Breast Cancer Cell Lines

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

Mesenchymal stem cells and cancer-associated fibroblasts as a therapeutic strategy for breast cancer

Francisco Raul Borzone et al.

Summary: Breast cancer is the most common cancer in women and mesenchymal stromal/stem cells and cancer-associated fibroblasts (CAFs) play important roles in cancer progression, invasion, and therapy resistance. Targeting these cells and the tumor microenvironment can improve patients' response to treatment and survival rates.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Genetics & Heredity

Breast tumor microenvironment structures are associated with genomic features and clinical outcome

Esther Danenberg et al.

Summary: Imaging mass cytometry profiling of 693 breast tumors revealed 10 recurrent tumor microenvironment spatial structures, associated with genomic profiles and outcomes. These multicellular structures within the TME, varying in vascular content, stromal activation, and leukocyte composition, could improve patient stratification and link spatial organization to local TME function.

NATURE GENETICS (2022)

Article Multidisciplinary Sciences

Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+breast tumors

Elisa Rivas et al.

Summary: This study identifies a population of cancer-associated fibroblasts that are involved in suppressing the effectiveness of trastuzumab-induced ADCC in HER2+ breast cancer patients who do not respond to HER2-targeted therapy. The presence of this cellular subset, activated by TGF-beta, is related to low IL2 activity in the tumor microenvironment. Stimulation of the IL2 pathway in the tumor stroma restores the anti-cancer efficiency of trastuzumab in unresponsive tumors.

NATURE COMMUNICATIONS (2022)

Article Cell Biology

A proliferative to invasive switch is mediated by srGAP1 downregulation through the activation of TGF-(32 signaling

Chandrani Mondal et al.

Summary: In this study, srGAP1 is identified as a regulator of the proliferative-to-invasive switch in breast cancer cells. srGAP1low cells display a motile and invasive phenotype, facilitating the extravasation of cancer cells from blood vessels and attenuating tumor growth. Interestingly, a population of srGAP1low cells remain as solitary disseminated tumor cells in the lungs.

CELL REPORTS (2022)

Article Oncology

Adipocyte-derived extracellular vesicles promote breast cancer cell malignancy through HIF-1α activity

Giusi La Camera et al.

Summary: The study demonstrates that adipocyte-derived EVs can enhance breast cancer cell malignancy through the induction of HIF-1 alpha activity, with EV release in obese settings playing a potentially key role in breast cancer progression.

CANCER LETTERS (2021)

Review Cell & Tissue Engineering

Adipose tissue-derived stem cells in breast reconstruction: a brief review on biology and translation

Jun Fang et al.

Summary: Recent advances in ADSC biology offer new prospects in tissue engineering and regenerative medicine. ADSCs, with their pluripotent activity, paracrine activity, and immunomodulatory function, have shown promising therapeutic effects in treating autoimmune disorders, neurodegenerative diseases, and ischemic conditions. CAL based on ADSCs has improved fat graft retention and holds potential for breast reconstruction in breast cancer patients, despite facing challenges such as lack of standardized procedures and controversy over effectiveness.

STEM CELL RESEARCH & THERAPY (2021)

Article Oncology

Chemotherapy-triggered changes in stromal compartment drive tumor invasiveness and progression of breast cancer

Jana Plava et al.

Summary: Chemotherapy can affect mesenchymal stromal cells, influencing tumor cell behavior and treatment response, promoting tumor invasion and metastasis.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Review Oncology

Hyperglycemia and Chemoresistance in Breast Cancer: From Cellular Mechanisms to Treatment Response

Jie Qiu et al.

Summary: This article focuses on the mechanisms of chemotherapy resistance in hyperglycemic breast cancer patients, including abnormal behaviors of cancer cells in the hyperglycemic microenvironment and the impact of abnormal glucose metabolism on key signaling pathways. Understanding the causes of drug resistance in hyperglycemic patients may help to better inform the development of effective treatments.

FRONTIERS IN ONCOLOGY (2021)

Review Cell Biology

Benefits of Zebrafish Xenograft Models in Cancer Research

Xingyu Chen et al.

Summary: Zebrafish are widely used in cancer research due to their low cost, quick establishment, and small sample size required. The zebrafish patient-derived xenograft (zPDX) models show promising evidence for short-term clinical treatment.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Endocrinology & Metabolism

In severe obesity, subcutaneous adipose tissue cell-derived cytokines are early markers of impaired glucose tolerance and are modulated by quercetin

Vittoria D'Esposito et al.

Summary: In individuals with severe obesity, inflammatory cytokines derived from adipose tissue contribute to the development of type 2 diabetes. Specifically, TNF alpha levels are elevated in adipose tissue and differentiated adipocytes from individuals with impaired glucose tolerance and type 2 diabetes, compared to those with normal glucose tolerance. The anti-inflammatory flavonoid quercetin may help attenuate this inflammatory response and potentially prevent the progression to type 2 diabetes in severe obesity.

INTERNATIONAL JOURNAL OF OBESITY (2021)

Article Oncology

CD73-Mediated Immunosuppression Is Linked to a Specific Fibroblast Population That Paves the Way for New Therapy in Breast Cancer

Ilaria Magagna et al.

Summary: The study highlights the key role of CD73 in immunosuppressive CAF-S1 in breast cancer, showing that targeting CD73 can reduce CAF-S1-mediated immunosuppression. This provides a new promising therapeutic strategy for breast cancer patients.

CANCERS (2021)

Review Biology

The Zebrafish Xenograft Models for Investigating Cancer and Cancer Therapeutics

John T. Gamble et al.

Summary: Zebrafish xenograft models provide a rapid and efficient platform for testing the safety and efficacy of cancer drugs. Sharing around 80% of disease-related genes with humans, zebrafish offer a cost-effective, high-throughput alternative to mouse xenografts that is more relevant to human biology.

BIOLOGY-BASEL (2021)

Review Cell Biology

Heterogeneity within molecular subtypes of breast cancer

Kevin M. Turner et al.

Summary: Breast cancer exemplifies how molecular characterization influences therapeutic decisions. The compartmentalization of breast cancer into diverse subtypes is well-documented, but intratumoral heterogeneity, driven by both intrinsic and extrinsic factors, complicates this model. Evidence suggests that intratumoral molecular subtypes are dynamic and interconversion between subtypes contributes to tumor progression, metastases, and treatment resistance. Therapeutic strategies need to address this heterogeneity to improve treatment outcomes.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2021)

Review Oncology

Fibroblast Activation Protein-α as a Target in the Bench-to-Bedside Diagnosis and Treatment of Tumors: A Narrative Review

Lei Xin et al.

Summary: FAP, specifically expressed by activated fibroblasts, plays a crucial role in promoting tumor growth, invasion, metastasis, and immunosuppression. Through influencing extracellular matrix remodeling, intracellular signaling, and immunosuppression, CAF overexpression of FAP promotes tumor development and metastasis.

FRONTIERS IN ONCOLOGY (2021)

Review Oncology

Regulation of cancer stem cells in triple negative breast cancer

Norman Fultang et al.

Summary: Triple Negative Breast Cancer (TNBC) is the most lethal subtype of breast cancer with higher rates of relapse, recurrence, and therapy failure. Accumulation of therapy resistant Cancer Stem Cell (CSC) populations within TNBC contributes to poor clinical outcomes, influenced by cellular signaling pathways and transcription factors.

CANCER DRUG RESISTANCE (2021)

Article Cell & Tissue Engineering

Platelet-rich plasma counteracts detrimental effect of high-glucose concentrations on mesenchymal stem cells from Bichat fat pad

Vittoria D'Esposito et al.

JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (2020)

Review Oncology

Metabolic Reprogramming in Triple-Negative Breast Cancer

Sun Xiangyu et al.

FRONTIERS IN ONCOLOGY (2020)

Review Cell & Tissue Engineering

The Role and Specific Mechanism of OCT4 in Cancer Stem Cells: A Review

Qi Zhang et al.

INTERNATIONAL JOURNAL OF STEM CELLS (2020)

Review Oncology

Biomarkers for cancer-associated fibroblasts

Chencheng Han et al.

BIOMARKER RESEARCH (2020)

Review Oncology

Hyperinsulinaemia in cancer

Emily J. Gallagher et al.

NATURE REVIEWS CANCER (2020)

Article Oncology

A framework for advancing our understanding of cancer-associated fibroblasts

Erik Sahai et al.

NATURE REVIEWS CANCER (2020)

Article Multidisciplinary Sciences

Cells exhibiting strong p16INK4a promoter activation in vivo display features of senescence

Jie-Yu Liu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Review Biochemistry & Molecular Biology

Adipose-Derived Stem Cells in Cancer Progression: New Perspectives and Opportunities

Maria Giovanna Scioli et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Oncology

Cancer-associated adipocytes: key players in breast cancer progression

Qi Wu et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

Review Endocrinology & Metabolism

Stem cells in the treatment of diabetes mellitus - Focus on mesenchymal stem cells

Guenter Paeth et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2019)

Article Endocrinology & Metabolism

Scutellarin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF/ERK/FAK/Src Pathway Signaling

Lingli Long et al.

JOURNAL OF DIABETES RESEARCH (2019)

Article Biochemistry & Molecular Biology

Post-translational modification of OCT4 in breast cancer tumorigenesis

Yunhee Cho et al.

CELL DEATH AND DIFFERENTIATION (2018)

Review Cell Biology

Anatomical, Physiological, and Functional Diversity of Adipose Tissue

Rachel K. Zwick et al.

CELL METABOLISM (2018)

Review Biotechnology & Applied Microbiology

Targeting adipose tissue in the treatment of obesity-associated diabetes

Christine M. Kusminski et al.

NATURE REVIEWS DRUG DISCOVERY (2016)

Article Cell Biology

Glutamine Metabolism Regulates the Pluripotency Transcription Factor OCT4

Glenn Marsboom et al.

CELL REPORTS (2016)

Review Biochemistry & Molecular Biology

Senescence in Human Mesenchymal Stem Cells: Functional Changes and Implications in Stem Cell-Based Therapy

Valentina Turinetto et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Review Endocrinology & Metabolism

The CXCR1/2 Pathway: Involvement in Diabetes Pathophysiology and Potential Target for T1D Interventions

Antonio Citro et al.

CURRENT DIABETES REPORTS (2015)

Review Biochemistry & Molecular Biology

Pluripotency Genes and Their Functions in the Normal and Aberrant Breast and Brain

Tracy Seymour et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)

Article Cell & Tissue Engineering

Expression of α-Smooth Muscle Actin Determines the Fate of Mesenchymal Stromal Cells

Nilesh P. Talele et al.

STEM CELL REPORTS (2015)

Editorial Material Medicine, General & Internal

The global implications of diabetes and cancer

Yuankai Shi et al.

LANCET (2014)

Review Biochemistry & Molecular Biology

Zebrafish embryo as a tool to study tumor/endothelial cell cross-talk

Chiara Tobia et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)

Article Biochemistry & Molecular Biology

Interleukin-8 in Breast Cancer Progression

Natasa Todorovic-Rakovic et al.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2013)

Review Biochemistry & Molecular Biology

Microenvironmental regulation of tumor progression and metastasis

Daniela F. Quail et al.

NATURE MEDICINE (2013)

Article Cell Biology

Lamin B1 loss is a senescence-associated biomarker

Adam Freund et al.

MOLECULAR BIOLOGY OF THE CELL (2012)

Article Oncology

Diabetes and prognosis in a breast cancer cohort

Michael G. Schrauder et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)

Article Oncology

Diabetes Mellitus and Breast Cancer Outcomes: A Systematic Review and Meta-Analysis

Kimberly S. Peairs et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Review Oncology

Diabetes and cancer

Paolo Vigneri et al.

ENDOCRINE-RELATED CANCER (2009)

Article Oncology

Diabetes mellitus and risk of breast cancer: A meta-analysis

Susanna C. Larsson et al.

INTERNATIONAL JOURNAL OF CANCER (2007)